Overall market sentiment has been down on Acasti Pharma Inc (ACST) stock lately. ACST receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.
Acasti Pharma Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ACST!
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With ACST Stock Today?
Acasti Pharma Inc (ACST) stock is trading at $2.80 as of 9:30 AM on Wednesday, Feb 14, a rise of $0.35, or 14.29% from the previous closing price of $2.45. The stock has traded between $2.80 and $2.80 so far today. Volume today is low. So far 8 shares have traded compared to average volume of 23,054 shares.
More About Acasti Pharma Inc
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes.
Click Here to get the full Stock Report for Acasti Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
